American Association for Cancer Research

Late-breaking Clinical Trials Teleconference

Bookmark and Share

This press conference, “Late-breaking Clinical Trials,” held on Saturday, March 31 was hosted José Baselga, M.D., Ph.D., associate director and chief of hematology/oncology at the Massachusetts General Hospital Cancer Center in Boston, Mass., and discusses the following research:

  • Early Clinical Data Show Galeterone Safe, Effective Against Prostate Cancer
  • Metformin Appeared to Slow Prostate Cancer Growth
  • Biomarker Identified in Relation to Drug Response in Refractory Urothelial Cancer
  • Combination Targeted Therapy Well Tolerated, Effective for Refractory Ewing’s Sarcoma Tumors
  • Selumetinib Controlled Recurrent Low-grade Serous Ovarian Cancer
  • Oral Vitamin D Supplements Reduced Levels of Ki67 in Prostate Cancer Cells
Listen to a recording of the teleconference:



Download* the mp3 of the teleconference (63.55 MB, 1 hour, 9 minutes and 24 seconds)

*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.